Full-Time

Insights COE Consultant

Posted on 5/8/2026

ClearView Healthcare Partners

ClearView Healthcare Partners

501-1,000 employees

Life sciences strategy consulting for biopharma

No salary listed

Noida, Uttar Pradesh, India

Hybrid

Hybrid role requires 3 days/week on-site at Gurgaon office.

Category
Consulting (2)
,
Required Skills
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • 4-6 years of experience in life sciences consulting, market research, competitive intelligence, HTA / HEOR support, or similar insights focused roles.
  • Undergraduate or master’s degree in a life science discipline (e.g., biology, biochemistry, pharmacology, biotechnology, pharmacy) or related field.
  • Demonstrated interest in the global biopharmaceutical industry and strategic questions related to R&D, commercialization, pricing & access, launch and lifecycle management, diagnostics, and corporate / investor strategy.
  • Ability to independently execute well-scoped research workstreams (e.g., literature scans, competitive profiles, basic epidemiology/market sizing desk research) with moderate oversight.
  • High attention to detail in referencing, data checking, and ensuring consistency of narratives and exhibits across multiple sources.
  • Strong written and verbal communication skills in English, with the ability to translate complex scientific and commercial concepts into accessible, actionable insights.
  • Highly analytical and structured approach to organizing information and building logical narratives from evidence.
  • Enthusiasm for collaborating with distributed global teams and comfort working across time zones.
  • Strong proficiency in Microsoft PowerPoint and Excel; familiarity with common life science data and literature sources (e.g., clinical trial registries, scientific literature, company reports, analyst reports) is a plus.
  • Ability to work in a hybrid setup, with 3 days per week from the Gurgaon office.
Responsibilities
  • Conduct targeted secondary research on diseases, therapies, competitors, clinical pipelines, and market dynamics using public and proprietary data sources (e.g., EvaluatePharma, GlobalData, Navlin, MMIT, AnswerSuite, company filings, HTA portals).
  • Synthesize research findings into clear, structured, and slide‑ready deliverables, including market landscapes, analytical frameworks, and concise written insights.
  • Develop disease, assets, and company overviews; treatment algorithms; guideline and standard of care maps; and epidemiology driven market context summaries to support a broad range of strategic work.
  • Perform analog research and benchmarking across launch, uptake, access, pricing, evidence generation, and go‑to‑market strategies to inform strategic decision‑making
  • Summarize HTA, payer, and reimbursement decisions, identifying key value messages, evidence expectations, pricing and access outcomes, and drivers of payer decisions across markets.
  • Prepare structured competitor and payer relevant profiles, including strategy, evidence, positioning, and deal or funding activity, to support both project and internal business development needs.
  • Build and maintain reusable research assets, including competitive landscapes, analog libraries, launch timelines, and technology and policy trend trackers.
  • Support qualitative research efforts by helping prepare discussion guides, synthesizing interview notes, and organizing insights for hypothesis testing.
  • Work with global consulting colleagues to clarify problem statements, refine research questions, and iteratively improve output based on feedback.
  • Contribute to the creation of templated outputs that integrate research insights into overall project deliverables (e.g., storyline aligned slides, appendices, and supporting materials).
  • Ensure quality and consistency of research outputs by adhering to internal standards, referencing guidelines, and formatting best practices.
  • Participate in internal knowledge building initiatives, including upkeep of internal knowledge repositories, templates, and best practice examples.
ClearView Healthcare Partners

ClearView Healthcare Partners

View

ClearView Healthcare Partners provides strategic consulting services exclusively for the life sciences sector, guiding pharmaceutical, biotechnology, medical devices, and diagnostics firms through decisions from discovery to commercialization. It completes project work with 100% of a dedicated team focused on a single client engagement, pairing rigorous scientific knowledge with business strategy, with many consultants holding life sciences PhDs. The firm differentiates itself through its strict one-client-per-project model, sector-only focus, and deep scientific expertise, plus international expansion to serve global clients. Its goal is to help life sciences companies grow, advance product development, and secure market access, creating value across the entire product lifecycle.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Newton, Massachusetts

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Gurgaon office expands Asia-Pacific client reach since 2025.
  • $4M Epistemic AI investment enhances AI-driven biomedical analysis.
  • 330 employees position as largest independent life sciences consultancy.

What critics are saying

  • Founder departures destabilize leadership post-GHO 2021 acquisition.
  • Pharma M&A cuts consulting budgets through 2025.
  • McKinsey life sciences hires poach PhD consultants immediately.

What makes ClearView Healthcare Partners unique

  • 100% project team dedication ensures focused life sciences strategy.
  • Over half consultants hold life sciences PhDs for scientific rigor.
  • Exclusive focus on pharma, biotech, medtech growth strategies.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at ClearView Healthcare Partners who can refer or advise you

Benefits

Hybrid Work Options

Remote Work Options

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Wellness Program

Mental Health Support

Professional Development Budget

Conference Attendance Budget

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Home Office Stipend

Phone/Internet Stipend

Parental Leave

Adoption Assistance

Meal Benefits

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Training Programs

Company News

PR Newswire
Mar 12th, 2025
The Addf'S Diagnostics Accelerator Authors New Paper On Ocular Biomarker Landscape, Highlighting Ocular Tests As A Tool For Early Detection Of Alzheimer'S Disease

New findings published in Alzheimer's Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's, while ocular tests offer a non-invasive alternative for detecting at-risk patient populations NEW YORK, March 12, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) authored a first-of-its-kind paper, "Unlocking ocular biomarkers for early detection of Alzheimer's disease," providing a landscape review of ocular biomarkers as another tool, alongside blood biomarkers, to aid in the early detection of Alzheimer's disease. The paper, which was published in Alzheimer's Dementia, shares an informed perspective on the role of ocular biomarkers in the broader Alzheimer's diagnostics space and what defines a true ocular biomarker, while also highlighting the potential for ocular screening to identify at-risk patients who would otherwise go undiagnosed. The authors' assessment is based on hours of in-depth interviews with leading neurologists, ophthalmologists, optometrists, and primary care physicians from across the United States

CityBiz
Jan 13th, 2025
ClearView Invests $4M in Epistemic AI

ClearView Healthcare Partners announced a $4 million minority investment in Epistemic AI to enhance its EpistemicGPT platform, which combines AI with a vast biomedical knowledge graph. This partnership aims to improve ClearView's service offerings by integrating AI technology, enhancing research and drug development processes. The collaboration underscores a commitment to advancing biomedical research and healthcare outcomes through innovative technology solutions.

CityBiz
Jan 13th, 2025
ClearView Healthcare Partners Invest In Epistemic AI

BOSTON, MA and WESTPORT, CT – 13 January 2025: ClearView Healthcare Partners, the leading life sciences strategic consultancy supporting Pharma... Read More

Digital Therapeutics Alliance
Nov 15th, 2023
DTx Commercialization Launch Playbook Case Study

Digital Therapeutics Alliance is thrilled to announce the release of its latest white paper in collaboration with Clearview Healthcare Partners!

Foundation Fighting Blindness
Feb 13th, 2023
The Foundation's long-term impact on moving the inherited retinal disease field forward towards treatments and cures. — Foundation Fighting Blindness

The Foundation Fighting Blindness partnered with ClearView Healthcare Partners to evaluate the impact of its funding and resources since 2005 on the clinical understanding and development of novel therapies for inherited retinal diseases (IRDs).